Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epidermal Growth Factor Receptor Inhibitors for Lung Cancer and the Risk of Keratitis.

JAMA ophthalmology - 1 Feb 2024

Huang Pin-Chia, Lin Ching-Chieh, Dana Reza, Ma Kevin Sheng-Kai

Abstract excerpt

Importance: Epidermal growth factor receptor inhibitors (EGFRis) have been reported to be associated with cutaneous and ocular side effects; however, there is limited evidence of an association between EGFRi treatment and keratitis. Objective: To determine the association between EGFRi treatment and agents and the risk of new-onset keratitis among patients with lung cancer. Design, Setting, and Participants: This...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Afatinib
Share to Aged
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Keratitis

Share to Lung Neoplasms

Share to Mutation

Share to Protein Kinase Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 38206621
DOI: 10.1001/jamaophthalmol.2023.6089
PMCID: PMC10784992

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epidermal Growth Factor Receptor Inhibitors for Lung Cancer and the Risk of Keratitis.PMID 38206621Read ↗

Relationship between Epidermal Growth Factor Receptor Mutations and Adverse Events in Non-Small Cell Lung Cancer Patients treated with Afatinib.Semantic proximity Read ↗

Eye, hepatobiliary, and renal disorders of erlotinib in patients with non-small-cell lung cancer: A meta-analysis.Semantic proximity Read ↗

Purchase of prophylactic topical corticosteroids is associated with improved survival in NSCLCs treated with EGFR TKI: real-world cohort study.Semantic proximity Read ↗

Incidence and Prevalence of Keratoconus in Taiwan During 2000–2018 and Their Association With Topography UseSemantic proximity Read ↗

Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors for non-small cell lung cancerSemantic proximity Read ↗

Eye, Hepatobiliary, and Renal Disorders of Erlotinib in Patients with Non-Small-Cell Lung Cancer: A Meta-AnalysisSemantic proximity Read ↗

Personalized Management for EGFRI-Induced Skin Xerosis and Pruritus in NSCLC: A Randomized Trial of a Targeted Repair Balm versus an Emollient 'Plus'Semantic proximity Read ↗

Afatinib-associated Stevens-Johnson syndrome in an EGFR-mutated lung cancer patient.Semantic proximity Read ↗

Drug-induced Hypersensitivity Syndrome by EGFR-TKI in a Patient with Lung Cancer.Semantic proximity Read ↗

Association between dermatologic adverse events and quality of life in lung cancer patients treated with epidermal growth factor receptor-tyrosine kinase inhibitors.Semantic proximity Read ↗

Voriconazole Metabolism is Associated with the Number of Skin Cancers Per PatientSemantic proximity Read ↗

A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Topical Urea for Secondary Prophylaxis of Hand Foot Skin Reaction in Renal Cell Cancer Patients on Sunitinib Therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.